As of today (2024-05-23), HST Global's share price is $1.08.
HST Global's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.01. Hence, HST Global's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for HST Global's Price-to-Free-Cash-Flow or its related term are showing as below:
HSTC's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.86 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 12.60% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 24.60% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 9.50% per year.
During the past 13 years, HST Global's highest 3-Year average Free Cash Flow per Share Growth Rate was 72.20% per year. The lowest was -246.40% per year. And the median was 14.40% per year.
HST Global Price-to-Free-Cash-Flow Historical Data
The historical data trend for HST Global's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of HST Global's Price-to-Free-Cash-Flow
For the Biotechnology subindustry, HST Global's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HST Global's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, HST Global's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where HST Global's Price-to-Free-Cash-Flow falls into.
HST Global Price-to-Free-Cash-Flow Calculation
HST Global's Price-to-Free-Cash-Flow ratio for today is calculated as
HST Global's Share Price of today is $1.08. HST Global's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
HST Global (OTCPK:HSTC) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
HST Global Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of HST Global's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers that are focused on the homeopathic and alternative treatment of late-stage cancer. Further, it primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out through the region of the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HSTC has been successfully added to your 